Literature DB >> 28437324

Noncirrhotic Portal Fibrosis in Pediatric Population.

Vikrant Sood1, Bikrant B Lal, Rajeev Khanna, Dinesh Rawat, Chhagan Bihari, Seema Alam.   

Abstract

OBJECTIVES: Noncirrhotic portal fibrosis (NCPF) has been classically described as a disease of young to middle age with limited literature regarding its occurrence, onset, or clinical presentation in children. We hereby present a series of 19 patients diagnosed and managed as NCPF in pediatric age group.
METHODS: A retrospective review of all the patients presenting to the pediatric hepatology department (age <18 years) and diagnosed as NCPF was done and data were evaluated.
RESULTS: A total of 19 patients were diagnosed as NCPF with median age at onset of symptoms and diagnosis as 10 years and 13.8 years respectively. Majority presented with left upper quadrant discomfort or mass. Laboratory parameters showed hypersplenism in majority with preserved liver synthetic functions. Median values for hepatic venous pressure gradient and liver stiffness measurement were 13.5 mmHg and 10.6 kPa, respectively. Classical hepatic histopathological features seen were maintained lobular architecture, atretic portal tracts, approximation of portal-portal and portal-central areas, and aberrant peripheral portal channels. During follow-up, majority of the patients did not show disease progression.
CONCLUSIONS: NCPF is not an uncommon entity in pediatric population with age of onset in early second decade. Hepatic histopathology must be used to exclude cirrhosis and to confirm the diagnosis. Hepatic venous pressure gradient and liver stiffness measurement values, in some cases, may overlap with those in patients with cirrhosis and may not be diagnostic in isolation. Any patient presenting with evidence of portal hypertension with preserved hepatic functions, irrespective of the age, should be evaluated for possible NCPF.

Entities:  

Mesh:

Year:  2017        PMID: 28437324     DOI: 10.1097/MPG.0000000000001485

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.

Authors:  Abhijit Chougule; Archana Rastogi; Rakhi Maiwall; Chhagan Bihari; Vikrant Sood; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-04-12       Impact factor: 6.047

2.  Pediatric non-cirrhotic portal fibrosis: role of endoscopic management in determining long-term outcome.

Authors:  Durga Prasad; Moinak Sen Sarma; Surender Kumar Yachha; Anshu Srivastava; Ujjal Poddar
Journal:  Hepatol Int       Date:  2019-08-29       Impact factor: 6.047

3.  Long-term outcome of pediatric non-cirrhotic portal fibrosis from the viewpoint of endoscopic profile.

Authors:  Kohei Kotani; Norifumi Kawada
Journal:  Hepatol Int       Date:  2020-03-13       Impact factor: 6.047

Review 4.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

Review 5.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.

Authors:  Michel Kmeid; Xiuli Liu; Samuel Ballentine; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2021-04-21

Review 6.  Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.

Authors:  Oana Nicoară-Farcău; Ioana Rusu; Horia Stefănescu; Marcel Tanțău; Radu Ion Badea; Bogdan Procopeț
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

Review 7.  What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors.

Authors:  Ashish Goel; Banumathi Ramakrishna; Uday Zachariah; K G Sajith; Deepak K Burad; Thomas A Kodiatte; Shyamkumar N Keshava; K A Balasubramanian; Elwyn Elias; C E Eapen
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.